Clinical efficacy of osimertinib for a patient with ileus due to peritoneal carcinomatosis

Abstract

Abstract We report a patient of stage IV lung adenocarcinoma who developed ileus due to peritoneal carcinomatosis. We placed an ileus tube and started an oral intake of osimertinib. Within one month, the tumor had shrunk, and the ileus was controlled.

Keywords

• ileus
• lung cancer
• osimertinib
• peritoneal carcinomatosis
• pharmacokinetics